{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:06:00Z","timestamp":1793066760704,"version":"4.5.0"},"reference-count":42,"publisher":"Bentham Science Publishers Ltd.","issue":"22","funder":[{"DOI":"10.13039\/100007637","name":"COLCIENCIAS (Programa Nacional de Formaci\u00f3n de Investigadores","doi-asserted-by":"publisher","award":["647 - 2015"],"award-info":[{"award-number":["647 - 2015"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003105","name":"Federal University of Uberlandia","doi-asserted-by":"publisher","award":["5.313-15"],"award-info":[{"award-number":["5.313-15"]}],"id":[{"id":"10.13039\/501100003105","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["465669\/2014-0"],"award-info":[{"award-number":["465669\/2014-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["CBB-APQ-03613-17"],"award-info":[{"award-number":["CBB-APQ-03613-17"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["CBB-APQ-01637-15"],"award-info":[{"award-number":["CBB-APQ-01637-15"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["CBB-APQ-01401-17"],"award-info":[{"award-number":["CBB-APQ-01401-17"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["5.313-15"],"award-info":[{"award-number":["5.313-15"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007329","name":"Universidad del Valle","doi-asserted-by":"publisher","award":["71144"],"award-info":[{"award-number":["71144"]}],"id":[{"id":"10.13039\/501100007329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2019,10,24]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Disintegrins from snake venoms bind with high specificity cell surface integrins,\nwhich are important pharmacological targets associated with cancer development and progression.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>In this study, we isolated a disintegrin from the Porthidium lansbergii lansbergii venom and\nevaluated its antitumoral effects on breast cancer cells.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The isolation of the disintegrin was performed on RP-HPLC and the inhibition of platelet aggregation\nwas evaluated on human platelet-rich plasma. The inhibition of cell adhesion was also evaluated\nin vitro on cultures of cell lines by the MTT method as well as the inhibition of breast cancer cell\nmigration by the wound healing assay. The binding of the disintegrin to integrin subunits was verified by\nflow cytometry and confocal microscopy. Finally, inhibition of angiogenesis was assessed in vitro on\nHUVEC cells and the concentration of VEGF was measured in the cellular supernatants.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The disintegrin, named Lansbermin-I, is a low molecular weight protein (&lt; 10 kDa) that includes\nan RGD on its sequence identified previously. Lansbermin-I showed potent inhibition of ADP and\ncollagen-induced platelet aggregation on human plasma and also displayed inhibitory effects on the adhesion\nand migration of breast cancer MCF7 and MDA-MB 231cell lines, without affecting nontumorigenic\nbreast MCF-10A and lung BEAS cells. Additionally, Lansbermin-I prevented MCF7 cells to\nadhere to fibronectin and collagen, and also inhibited in vitro angiogenesis on human endothelial HUVEC\ncells.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Our results display the first report on the antitumor and anti-metastatic effects of an RGDdisintegrin\nisolated from a Porthidium snake venom by possibly interfering with \u03b12 and\/or \u03b21-containing\nintegrins. Thus, Lansbermin-I could be an attractive model to elucidate the role of disintegrins against\nbreast cancer development.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1568026619666190806151401","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T10:45:49Z","timestamp":1565088349000},"page":"2069-2078","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Antitumoral Potential of Lansbermin-I, a Novel Disintegrin from Porthidium lansbergii lansbergii Venom on Breast Cancer Cells"],"prefix":"10.2174","volume":"19","author":[{"given":"Leonel","family":"Montealegre-S\u00e1nchez","sequence":"first","affiliation":[{"name":"Grupo de Nutricion, Facultad de Salud, Universidad del Valle, Cali, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah N.C.","family":"Gimenes","sequence":"additional","affiliation":[{"name":"Laboratorio de Bioqui\u00admica e Toxinas Animais, Instituto de Biotecnologia, Universidade Federal de Uberlandia, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiana S.","family":"Lopes","sequence":"additional","affiliation":[{"name":"Instituto Multidisciplinar em Saude, Campus Ani\u00adsio Teixeira, Universidade Federal da Bahia, BA, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel C.","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Laboratorio de Bioqui\u00admica e Toxinas Animais, Instituto de Biotecnologia, Universidade Federal de Uberlandia, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Solano-Redondo","sequence":"additional","affiliation":[{"name":"Grupo Laboratorio de Herpetologi\u00ada, Facultad de Ciencias, Universidad del Valle, Cali, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veridiana","family":"de Melo Rodrigues","sequence":"additional","affiliation":[{"name":"Laboratorio de Bioqui\u00admica e Toxinas Animais, Instituto de Biotecnologia, Universidade Federal de Uberlandia, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli\u00e9cer","family":"Jim\u00e9nez-Charris","sequence":"additional","affiliation":[{"name":"Grupo de Nutricion, Facultad de Salud, Universidad del Valle, Cali, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3390\/toxins10090346","volume":"10","author":"Li L.","year":"2018","unstructured":"Li L.; Huang J.; Lin Y.; Snake venoms in cancer therapy: Past, present and future. Toxins (Basel) 2018,10(9),346","journal-title":"Toxins (Basel)"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1093\/molbev\/msn179","volume":"25","author":"Ju\u00e1rez P.","year":"2008","unstructured":"Ju\u00e1rez P.; Comas I.; Gonz\u00e1lez-Candelas F.; Calvete J.J.; Evolution of snake venom disintegrins by positive Darwinian selection. Mol Biol Evol 2008,25(11),2391-2407","journal-title":"Mol Biol Evol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jprot.2014.11.016","volume":"114","author":"Jim\u00e9nez-Charris E.","year":"2015","unstructured":"Jim\u00e9nez-Charris E.; Montealegre-Sanchez L.; Solano-Redondo L.; Mora-Obando D.; Camacho E.; Castro-Herrera F.; Fierro-P\u00e9rez L.; Lomonte B.; Proteomic and functional analyses of the venom of Porthidium lansbergii lansbergii (Lansberg\u2019s hognose viper) from the Atlantic Department of Colombia. J Proteomics 2015,114,287-299","journal-title":"J Proteomics"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.toxicon.2007.07.016","volume":"50","author":"Oliva I.B.","year":"2007","unstructured":"Oliva I.B.; Coelho R.M.; Barcellos G.G.; Saldanha-Gama R.; Wermelinger L.S.; Marcinkiewicz C.; Benedeta Zingali R.; Barja-Fidalgo C.; Effect of RGD-disintegrins on melanoma cell growth and metastasis: involvement of the actin cytoskeleton, FAK and c-Fos. Toxicon 2007,50(8),1053-1063","journal-title":"Toxicon"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"Desgrosellier J.S.","year":"2010","unstructured":"Desgrosellier J.S.; Cheresh D.A.; Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2010,10(1),9-22","journal-title":"Nat Rev Cancer"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.procbio.2012.04.020","volume":"47","author":"Thangam R.","year":"2012","unstructured":"Thangam R.; Gunasekaran P.; Kaveri K.; Sridevi G.; Sundarraj S.; Paulpandi M.; Kannan S.; A novel disintegrin protein from naja naja venom induces cytotoxicity and apoptosis in human cancer cell lines in vitro. Process Biochem 2012,47,1243-1249","journal-title":"Process Biochem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1042\/bj20021739","volume":"372","author":"Calvete J.J.","year":"2003","unstructured":"Calvete J.J.; Moreno-Murciano M.P.; Theakston R.D.G.; Kisiel D.G.; Marcinkiewicz C.; Snake venom disintegrins: Novel dimeric disintegrins and structural diversification by disulphide bond engineering. Biochem J 2003,372(Pt 3),725-734","journal-title":"Biochem J"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.toxicon.2005.01.013","volume":"45","author":"Yang R-S.","year":"2005","unstructured":"Yang R-S.; Tang C-H.; Chuang W-J.; Huang T-H.; Peng H-C.; Huang T-F.; Fu W-M.; Inhibition of tumor formation by snake venom disintegrin. Toxicon 2005,45(5),661-669","journal-title":"Toxicon"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.2174\/138161207782023793","volume":"13","author":"Swenson S.","year":"2007","unstructured":"Swenson S.; Ramu S.; Markland F.S.; Anti-angiogenesis and RGD-containing snake venom disintegrins. Curr Pharm Des 2007,13(28),2860-2871","journal-title":"Curr Pharm Des"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.toxicon.2012.09.005","volume":"62","author":"Calvete J.J.","year":"2013","unstructured":"Calvete J.J.; The continuing saga of snake venom disintegrins. Toxicon 2013,62,40-49","journal-title":"Toxicon"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nrc3397","volume":"12","author":"Umar A.","year":"2012","unstructured":"Umar A.; Dunn B.K.; Greenwald P.; Future directions in cancer prevention. Nat Rev Cancer 2012,12(12),835-848","journal-title":"Nat Rev Cancer"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.flm.2017.06.001","volume":"1","author":"Ke X.","year":"2017","unstructured":"Ke X.; Shen L.; Molecular targeted therapy of cancer: The progress and future prospect. Front Lab Med 2017,1,69-75","journal-title":"Front Lab Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40659-017-0140-9","volume":"50","author":"Akram M.","year":"2017","unstructured":"Akram M.; Iqbal M.; Daniyal M.; Khan A.U.; Awareness and current knowledge of breast cancer. Biol Res 2017,50(1),33","journal-title":"Biol Res"},{"key":"ref=14","first-page":"149","author":"Reeder J.G.","year":"2008","unstructured":"Reeder J.G.; Vogel V.G.;  Advances in Breast Cancer Management 2008,149-164","journal-title":"Advances in Breast Cancer Management"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"Bray F.","year":"2018","unstructured":"Bray F.; Ferlay J.; Soerjomataram I.; Siegel R.L.; Torre L.A.; Jemal A.; Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018,68(6),394-424","journal-title":"CA Cancer J Clin"},{"key":"ref=16","first-page":"3754","volume":"59","author":"Kang I.C.","year":"1999","unstructured":"Kang I.C.; Lee Y.D.; Kim D.S.; A novel disintegrin salmosin inhibits tumor angiogenesis. Cancer Res 1999,59(15),3754-3760","journal-title":"Cancer Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1177\/1087057110361772","volume":"15","author":"Yue P.Y.K.","year":"2010","unstructured":"Yue P.Y.K.; Leung E.P.Y.; Mak N.K.; Wong R.N.S.; A simplified method for quantifying cell migration\/wound healing in 96-well plates. J Biomol Screen 2010,15(4),427-433","journal-title":"J Biomol Screen"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.ijbiomac.2018.09.053","volume":"122","author":"Jim\u00e9nez-Charris E.","year":"2019","unstructured":"Jim\u00e9nez-Charris E.; Lopes D.S.; Gimenes S.N.C.; Teixeira S.C.; Montealegre-S\u00e1nchez L.; Solano-Redondo L.; Fierro-P\u00e9rez L.; Rodrigues \u00c1vila V.M.; Antitumor potential of Pllans-II, an acidic Asp49-PLA from Porthidium lansbergii lansbergii snake venom on human cervical carcinoma HeLa cells. Int J Biol Macromol 2019,122,1053-1061","journal-title":"Int J Biol Macromol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1475-2867-9-7","volume":"9","author":"Imbalzano K.M.","year":"2009","unstructured":"Imbalzano K.M.; Tatarkova I.; Imbalzano A.N.; Nickerson J.A.; Increasingly transformed MCF-10A cells have a progressively tumor-like phenotype in three-dimensional basement membrane culture. Cancer Cell Int 2009,9,7","journal-title":"Cancer Cell Int"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"532","DOI":"10.2174\/1389203716666150515125002","volume":"16","author":"Arruda Mac\u00eado J.K.","year":"2015","unstructured":"Arruda Mac\u00eado J.K.; Fox J.W.; de Souza Castro M.; Disintegrins from snake venoms and their applications in cancer research and therapy. Curr Protein Pept Sci 2015,16(6),532-548","journal-title":"Curr Protein Pept Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.toxicon.2016.07.006","volume":"119","author":"Jim\u00e9nez-Charris E.","year":"2016","unstructured":"Jim\u00e9nez-Charris E.; Montealegre-S\u00e1nchez L.; Solano-Redondo L.; Castro-Herrera F.; Fierro-P\u00e9rez L.; Lomonte B.; Divergent functional profiles of acidic and basic phospholipases A2 in the venom of the snake Porthidium lansbergii lansbergii. Toxicon 2016,119,289-298","journal-title":"Toxicon"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1111\/j.1538-7836.2007.02671.x","volume":"5","author":"McLane M.A.","year":"2007","unstructured":"McLane M.A.; Paquette-Straub C.; Scientific and standardization committee communications: classification and nomenclature of disintegrins isolated from snake venoms. J Thromb Haemost 2007,5(9),1971-1971","journal-title":"J Thromb Haemost"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0041-0101(92)90869-7","volume":"30","author":"Kini R.M.","year":"1992","unstructured":"Kini R.M.; Evans H.J.; Structural domains in venom proteins: evidence that metalloproteinases and nonenzymatic platelet aggregation inhibitors (disintegrins) from snake venoms are derived by proteolysis from a common precursor. Toxicon 1992,30(3),265-293","journal-title":"Toxicon"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.biocel.2013.06.009","volume":"45","author":"Marcinkiewicz C.","year":"2013","unstructured":"Marcinkiewicz C.; Applications of snake venom components to modulate integrin activities in cell-matrix interactions. Int J Biochem Cell Biol 2013,45(9),1974-1986","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.bbrc.2018.03.169","volume":"499","author":"Singh C.","year":"2018","unstructured":"Singh C.; Shyanti R.K.; Singh V.; Kale R.K.; Mishra J.P.N.; Singh R.P.; Integrin expression and glycosylation patterns regulate cell-matrix adhesion and alter with breast cancer progression. Biochem Biophys Res Commun 2018,499(2),374-380","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"6617","DOI":"10.2741\/3177","volume":"13","author":"McLane M.A.","year":"2008","unstructured":"McLane M.A.; Joerger T.; Mahmoud A.; Disintegrins in health and disease. Front Biosci 2008,13,6617-6637","journal-title":"Front Biosci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"37809","DOI":"10.1074\/jbc.274.53.37809","volume":"274","author":"Wierzbicka-Patynowski I.","year":"1999","unstructured":"Wierzbicka-Patynowski I.; Niewiarowski S.; Marcinkiewicz C.; Calvete J.J.; Marcinkiewicz M.M.; McLane M.A.; Structural requirements of echistatin for the recognition of \u03b1(v)\u03b2(3) and \u03b1(5)\u03b2(1) integrins. J Biol Chem 1999,274(53),37809-37814","journal-title":"J Biol Chem"},{"key":"ref=28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175321","volume":"12","author":"Chang Y-T.","year":"2017","unstructured":"Chang Y-T.; Shiu J-H.; Huang C-H.; Chen Y-C.; Chen C-Y.; Chang Y-S.; Chuang W-J.; Effects of the RGD loop and C-terminus of rhodostomin on regulating integrin \u03b1IIb\u03b23 recognition. PLoS One 2017,12(4)","journal-title":"PLoS One"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2174\/1381612053381765","volume":"11","author":"Marcinkiewicz C.","year":"2005","unstructured":"Marcinkiewicz C.; Functional characteristic of snake venom disintegrins: potential therapeutic implication. Curr Pharm Des 2005,11(7),815-827","journal-title":"Curr Pharm Des"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1006\/abbi.2000.2120","volume":"384","author":"Souza D.H.","year":"2000","unstructured":"Souza D.H.; Iemma M.R.; Ferreira L.L.; Faria J.P.; Oliva M.L.; Zingali R.B.; Niewiarowski S.; Selistre-de-Araujo H.S.; The disintegrin-like domain of the snake venom metalloprotease alternagin inhibits alpha2beta1 integrin-mediated cell adhesion. Arch Biochem Biophys 2000,384(2),341-350","journal-title":"Arch Biochem Biophys"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0945-053X(02)00068-9","volume":"21","author":"Eble J.A.","year":"2002","unstructured":"Eble J.A.; Niland S.; Dennes A.; Schmidt-Hederich A.; Bruckner P.; Brunner G.; Rhodocetin antagonizes stromal tumor invasion in vitro and other alpha2beta1 integrin-mediated cell functions. Matrix Biol 2002,21(7),547-558","journal-title":"Matrix Biol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1593\/neo.07898","volume":"10","author":"Rosenow F.","year":"2008","unstructured":"Rosenow F.; Ossig R.; Thormeyer D.; Gasmann P.; Schl\u00fcter K.; Brunner G.; Haier J.; Eble J.A.; Integrins as antimetastatic targets of RGD-independent snake venom components in liver metastasis [corrected]. Neoplasia 2008,10(2),168-176","journal-title":"Neoplasia"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/sj.bjc.6603088","volume":"94","author":"Grzesiak J.J.","year":"2006","unstructured":"Grzesiak J.J.; Bouvet M.; The alpha2beta1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines. Br J Cancer 2006,94(9),1311-1319","journal-title":"Br J Cancer"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1593\/neo.08380","volume":"10","author":"Hall C.L.","year":"2008","unstructured":"Hall C.L.; Dubyk C.W.; Riesenberger T.A.; Shein D.; Keller E.T.; van Golen K.L.; Type I.; Type I collagen receptor (alpha2beta1) signaling promotes prostate cancer invasion through RhoC GTPase. Neoplasia 2008,10(8),797-803","journal-title":"Neoplasia"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40409-018-0150-2","volume":"24","author":"Moritz M.N. de O.","year":"2018","unstructured":"Moritz M.N. de O.; Eust\u00e1quio L.M.S.; Micocci K.C.; Nunes A.C.C.; dos Santos P.K.; de Castro Vieira, T.; Selistre-de-Araujo, H.S. Alternagin-C binding to A2\u03b21 integrin controls matrix metalloprotease-9 and matrix metalloprotease-2 in breast tumor cells and endothelial cells. J Venom Anim Toxins Incl Trop Dis 2018,24,13","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"7411","DOI":"10.1073\/pnas.92.16.7411","volume":"92","author":"Zutter M.M.","year":"1995","unstructured":"Zutter M.M.; Santoro S.A.; Staatz W.D.; Tsung Y.L.; Re-expression of the alpha 2 beta 1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci USA 1995,92(16),7411-7415","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/toxins9100307","volume":"9","author":"Monteiro D.A.","year":"2017","unstructured":"Monteiro D.A.; Selistre-de-Ara\u00fajo H.S.; Tavares D.; Fernandes M.N.; Kalinin A.L.; Rantin F.T.; Alternagin-C (ALT-C), a disintegrin-like Cys-rich protein isolated from the venom of the snake Rhinocerophis alternatus, stimulates angiogenesis and antioxidant defenses in the liver of freshwater fish, Hoplias malabaricus. Toxins (Basel) 2017,9(10),9","journal-title":"Toxins (Basel)"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/j.1349-7006.2007.00534.x","volume":"98","author":"Yamauchi M.","year":"2007","unstructured":"Yamauchi M.; Imajoh-Ohmi S.; Shibuya M.; Novel antiangiogenic pathway of thrombospondin-1 mediated by suppression of the cell cycle. Cancer Sci 2007,98(9),1491-1497","journal-title":"Cancer Sci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1006\/excr.1998.4012","volume":"240","author":"Lichtner R.B.","year":"1998","unstructured":"Lichtner R.B.; Howlett A.R.; Lerch M.; Xuan J-A.; Brink J.; Langton-Webster B.; Schneider M.R.; Negative cooperativity between alpha 3 \u03b2 1 and alpha 2 \u03b2 1 integrins in human mammary carcinoma MDA MB 231 cells. Exp Cell Res 1998,240(2),368-376","journal-title":"Exp Cell Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1016\/j.bbagen.2014.03.009","volume":"1840","author":"Silva M.C.C.","year":"2014","unstructured":"Silva M.C.C.; de Paula C.A.A.; Ferreira J.G.; Paredes-Gamero E.J.; Vaz A.M.S.F.; Sampaio M.U.; Correia M.T.S.; Oliva M.L.V.; \n                        Bauhinia forficata lectin (BfL) induces cell death and inhibits integrin-mediated adhesion on MCF7 human breast cancer cells. Biochim Biophys Acta 2014,1840(7),2262-2271","journal-title":"Biochim Biophys Acta"},{"key":"ref=41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046576","volume":"7","author":"Kato H.","year":"2012","unstructured":"Kato H.; Liao Z.; Mitsios J.V.; Wang H-Y.; Deryugina E.I.; Varner J.A.; Quigley J.P.; Shattil S.J.; The primacy of \u03b21 integrin activation in the metastatic cascade. PLoS One 2012,7(10)","journal-title":"PLoS One"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10555-005-5132-5","volume":"24","author":"Brakebusch C.","year":"2005","unstructured":"Brakebusch C.; F\u00e4ssler R.; \u03b2 1 integrin function in vivo: Adhesion, migration and more. Cancer Metastasis Rev 2005,24(3),403-411","journal-title":"Cancer Metastasis Rev"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/174126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T09:59:15Z","timestamp":1576058355000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/174126\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,24]]},"references-count":42,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2019,10,24]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026619666190806151401","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,24]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-01-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}